Macular Hole

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2025-06-19
EMA Withdrawn: Jetrea (ocriplasmin) — Inceptua AB
The EMA has withdrawn Jetrea (ocriplasmin) from the European market; the marketing authorization holder is Inceptua AB, with the withdrawal …